Orca Bio Presents Positive Data Reinforcing Clinical Profile

– Three oral presentations showcase clinical evidence for Orca Bio’s promising pipeline of early- and late-stage high-precision cell therapies –– Orca-T demonstrated high relapse-free survival in recipients with fully matched donors and early potential in patients with mismatched donors –– Orca-Q showed improved gra...

Related Keywords

United States , Texas , American , Ivan Dimov , Kelsey Grossman , Samer Srour , Joshua Murray , American Society Of Hematology , University Of Texas Md Anderson Cancer Center , Corporate Communications , Drug Administration , Department Of Stem Cell Transplantation , Orca Bio , Cellular Therapy Meetings , American Society , Annual Meeting , Stem Cell Transplantation , Cellular Therapy , Presentation Title , While Reducing Graft Versus Host Disease , High Precision Cell Therapy , Hematologic Malignancies , Orcaq Demonstrates Favorable , Relapse Free Survival , Haploidentical Donors , Future Costs , Health Outcomes , Regenerative Medicine Advanced Therapy ,